A MATRIX METALLOPROTEINASE INHIBITOR IMPROVES CARDIOVASCULAR AND HEPATO-CELLULAR FUNCTION FOLLOWING HEMORRHAGE AND RESUSCITATION.

Cellular Function ◽

Matrix metalloproteinase-inhibitor causes an activation of urokinase after experimental cerebral ischemia

Aktuelle Neurologie ◽

10.1055/s-2005-919692 ◽

2005 ◽

Vol 32 (S 4) ◽

Author(s):

D Burggraf ◽

M Dichgans ◽

G.F Hamann

Keyword(s):

Cerebral Ischemia ◽

Experimental Cerebral Ischemia

A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis

PLoS ONE ◽

10.1371/journal.pone.0172925 ◽

2017 ◽

Vol 12 (2) ◽

pp. e0172925 ◽

Cited By ~ 8

Author(s):

Dale B. Bosco ◽

Mark D. Roycik ◽

Yonghao Jin ◽

Martin A. Schwartz ◽

Ty J. Lively ◽

...

Keyword(s):

Stem Cell ◽

Mesenchymal Stem Cell ◽

Human Mesenchymal Stem Cell ◽

Synthetic Matrix

Efficacy of horse chestnut leaf extract ALH-L1005 as a matrix metalloproteinase inhibitor in ligature-induced periodontitis in canine model

Journal of Veterinary Science ◽

10.4142/jvs.2017.18.2.245 ◽

2017 ◽

Vol 18 (2) ◽

pp. 245 ◽

Cited By ~ 4

Author(s):

Se Eun Kim ◽

Tae Hyun Kim ◽

Shin Ae Park ◽

Won Tae Kim ◽

Young Woo Park ◽

...

Keyword(s):

Leaf Extract ◽

Canine Model ◽

Horse Chestnut ◽

Chestnut Leaf

What is an effective anti-angiogenic treatment against hepatocellula carcinoma?-matrix metalloproteinase inhibitor sensitivity

The American Journal of Gastroenterology ◽

10.1016/s0002-9270(02)04732-9 ◽

2002 ◽

Vol 97 (9) ◽

pp. S85-S86 ◽

Cited By ~ 1

Author(s):

Y ISHII

Keyword(s):

A Phase I Pharmacokinetic and Pharmacodynamic Study of S-3304, a Novel Matrix Metalloproteinase Inhibitor, in Patients with Advanced and Refractory Solid Tumors

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-1586 ◽

2007 ◽

Vol 13 (7) ◽

pp. 2091-2099 ◽

Cited By ~ 30

Author(s):

Alberto A. Chiappori ◽

S. Gail Eckhardt ◽

Ronald Bukowski ◽

Daniel M. Sullivan ◽

Minoru Ikeda ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Pharmacodynamic Study

Renoprotective Action of a Matrix Metalloproteinase Inhibitor in Progressive Mesangioproliferative Nephritis

Nephron Extra ◽

10.1159/000338801 ◽

2012 ◽

Vol 2 (1) ◽

pp. 133-146 ◽

Cited By ~ 1

Author(s):

Takayuki Kuroda ◽

Masao Masui ◽

Mitsuru Notoya ◽

Masashi Ito ◽

Yoshinori Tamura ◽

...

Keyword(s):

Inhibition of Articular Cartilage Degradation in Culture by a Novel Nonpeptidic Matrix Metalloproteinase Inhibitor

Annals of the New York Academy of Sciences ◽

10.1111/j.1749-6632.1999.tb07737.x ◽

1999 ◽

Vol 878 (1 INHIBITION OF) ◽

pp. 594-597 ◽

Cited By ~ 14

Author(s):

R. CLARK BILLINGHURST ◽

KEVIN O'BRIEN ◽

A. ROBIN POOLE ◽

C. WAYNE McILWRAITH

Keyword(s):

Articular Cartilage ◽

Cartilage Degradation ◽

The effect of a matrix metalloproteinase inhibitor on inflammation-mediated preterm delivery

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2007.01.043 ◽

2007 ◽

Vol 196 (6) ◽

pp. 551.e1-551.e3 ◽

Cited By ~ 14

Author(s):

Karen L. Koscica ◽

Cande V. Ananth ◽

Jessica Placido ◽

Sandra E. Reznik

Keyword(s):

Preterm Delivery ◽

Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells

Experimental Cell Research ◽

10.1016/s0014-4827(03)00355-0 ◽

2003 ◽

Vol 290 (2) ◽

pp. 437-446 ◽

Cited By ~ 53

Author(s):

Chintda Santiskulvong ◽

Enrique Rozengurt

Keyword(s):

Dna Synthesis ◽

Broad Spectrum ◽

Egf Receptor ◽

Receptor Transactivation

Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.9.9.2159 ◽

2000 ◽

Vol 9 (9) ◽

pp. 2159-2165 ◽

Cited By ~ 35

Author(s):

Roberto Scatena

Keyword(s):

Tissue Remodelling ◽

Pharmacological Approach